business π§ͺ Q-Line Biotech IPO details revealed
Q-Line Biotech is launching its maiden book building IPO to raise funds for its operations. The company, based in India, is involved in developing and manufacturing various diagnostic reagents and consumables. The IPO is set to mobilize Rs. 214.48 cr., with a price band of Rs. 326 - Rs. 343 per share, running from May 21 to May 25, 2026. Despite top-line growth, FY25 showed a bottom-line setback due to accounting adjustments, and it has significant contingent liabilities. Well-informed investors might consider moderate long-term funds for this issue. π